Creating new medicines requires hundreds of millions of dollars, often over decades. For all diseases, this is an unsustainable model of care. For rare diseases, this investment can be seen as prohibitively high for the relatively small patient population. Oligonucleotide-based medicines (OBMs), with a history of nearly four decades, is the ideal modality to solve this problem. Creyon Bio is determined to build a faster, more cost-effective path to new medicines that can be delivered to patients in time to make a difference, ultimately building toward a future where these medicines could even be created on demand. Our efforts release OBM technologies from inefficient traditional drug discovery processes and create the future of drug development we have all long imagined – safe, effective precision medicines delivered to the right cells at the right time.
Creyon is excited to partner with disease organizations and patient advocacy groups to set up pilot projects, build out processes for responding quickly to a disease diagnosis and rapidly develop candidate precision therapeutics for patients.
For patients in need of therapeutic options, waiting years for a drug to reach the market can have devastating outcomes. Creyon aims to drive conversations about how regulations can be evolved to align with current science. Building the ability to predict safety and efficacy of drugs without prolonged, expensive preclinical testing, we aim to deliver critical treatments to patients in time to change their lives.
This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.
If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.
Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.
Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.
Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.